Beth Taylor Sells 4,370 Shares of Inotiv, Inc. (NASDAQ:NOTV) Stock

Inotiv, Inc. (NASDAQ:NOTV) CFO Beth Taylor sold 4,370 shares of the business’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $4.01, for a total transaction of $17,523.70. Following the sale, the chief financial officer now directly owns 108,368 shares in the company, valued at $434,555.68. This trade represents a 3.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Beth Taylor also recently made the following trade(s):

• On Friday, January 31st, Beth Taylor sold 2,054 shares of Inotiv stock. The shares were sold at an average price of $4.46, for a total transaction of $9,160.84.

Inotiv Stock Performance

Shares of NOTV traded up $0.35 during trading hours on Thursday, reaching $4.25. 882,402 shares of the company traded hands, compared to its average volume of 695,682. The stock has a market capitalization of $143.31 million, a P/E ratio of -0.92 and a beta of 3.58. The company has a quick ratio of 1.28, a current ratio of 1.57 and a debt-to-equity ratio of 2.31. Inotiv, Inc. has a 12-month low of $1.23 and a 12-month high of $11.42. The business has a fifty day moving average price of $4.37 and a 200-day moving average price of $2.93.

Inotiv (NASDAQ:NOTV) last posted its quarterly earnings results on Wednesday, February 5th. The company reported ($0.42) EPS for the quarter, missing the consensus estimate of ($0.32) by ($0.10). Inotiv had a negative net margin of 25.40% and a negative return on equity of 15.41%. Equities analysts anticipate that Inotiv, Inc. will post -0.79 EPS for the current fiscal year.

Institutional Investors Weigh In On Inotiv

Several hedge funds have recently added to or reduced their stakes in the business. Two Sigma Advisers LP boosted its holdings in Inotiv by 31.6% in the fourth quarter. Two Sigma Advisers LP now owns 22,500 shares of the company’s stock valued at $93,000 after purchasing an additional 5,400 shares during the last quarter. Two Sigma Investments LP boosted its holdings in Inotiv by 67.8% in the fourth quarter. Two Sigma Investments LP now owns 71,689 shares of the company’s stock valued at $297,000 after purchasing an additional 28,965 shares during the last quarter. Mink Brook Asset Management LLC purchased a new stake in Inotiv in the fourth quarter valued at $223,000. Millennium Management LLC boosted its holdings in Inotiv by 553.7% in the fourth quarter. Millennium Management LLC now owns 287,899 shares of the company’s stock valued at $1,192,000 after purchasing an additional 243,860 shares during the last quarter. Finally, Cubist Systematic Strategies LLC boosted its holdings in Inotiv by 500.0% in the fourth quarter. Cubist Systematic Strategies LLC now owns 83,923 shares of the company’s stock valued at $347,000 after purchasing an additional 69,936 shares during the last quarter. 18.17% of the stock is owned by hedge funds and other institutional investors.

Inotiv Company Profile

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.